Northwest Biotherapeutics Inc., of Bethesda, Md., said it completed two financings totaling $35 million, which includes a $25 million equity investment by UK-based C.F. Woodford Equity Income Fund and a $10 million mortgage on the company's recently acquired UK facility. The mortgage has a two-year term and interest-only payments until maturity.